Pandion Therapeutics Announces Pricing of Initial Public Offering
July 16, 2020 21:01 ET
|
Pandion Therapeutics, Inc.
WATERTOWN, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet...